Volume 17, Number 5—May 2011
Research
Babesiosis in Lower Hudson Valley, New York, USA
Table 2
Characteristic | Value |
---|---|
Mean age, y, ± SD (range) | 54.1 ± 20.1 (21–95) |
Male, no. (%) | 13 (72.2) |
Mean time from symptom onset to diagnosis, d, ± SD (range) | 13.6 ± 9.28 (3–33) |
Recollection of tick bite within 30 d, no. (%), n = 16 | 3 (18.8) |
Temperature >38°C, no. (%) | 15 (83.3) |
Splenomegaly, no. (%), n = 13 | 2 (15.4) |
Mean initial parasitemia, %, ± SD (range), n = 17† | 4.49 ± 4.57 (0.01–14) |
Mean highest level of parasitemia, %, ± SD (range), n = 17† | 5.34 ± 5.79 (0.05–18) |
Mean initial leukocyte count × 109/L,± SD (range), n = 17 | 7.2 ± 3.38 (3.2–15.4) |
Lymphocyte count <1,000 ×106/L, no. (%), n = 12 | 5 (41.6) |
Mean hemoglobin minimum, g/dL,± SD (range) | 8.2 ± 1.98 (3.5–11.1) |
Mean platelets minimum, × 109/L, ± SD (range) | 110.8 ± 139.2 (19–615) |
Platelets minimum <150 × 109/L, no. (%) | 16 (88.9) |
Mean initial erythrocyte sedimentation rate, mm/h,± SD (range), n = 9 | 76.7 ± 33.3 (32–138) |
Mean initial lactate dehydrogenase, U/L, ± SD (range), n = 15 | 931.5 ± 562 (229–2074) |
Mean initial aspartate aminotransferase, U/L, ± SD (range) | 237.7 ± 366.9 (19–1450) |
Initial aspartate aminotransferase >30 U/L, no. (%) | 14 (77.8) |
Mean initial alanine aminotransferase, U/L, ± SD (range) | 110.2 ± 111 (16–433) |
Initial alanine aminotransferase >40 U/L, no. (%) | 13 (72.2) |
Mean initial total bilirubin, mg/dL, ± SD (range) | 3.4 ± 5.59 (0.4–24.6) |
Initial total bilirubin >1.2 mg/dL, no. (%) | 10 (55.6) |
Mean serum sodium minimum, meq/L, ± SD (range), n = 17 | 127.6 ± 10.1 (94–139) |
Mean creatinine maximum , ng/mL, ± SD (range), n = 17 | 1.3 ± 0.59 (0.7–2.7) |
*Data were obtained from all 18 patients unless otherwise indicated.
†For 1 patient with a positive smear, the level of parasitemia is unknown.
Page created: August 19, 2011
Page updated: August 19, 2011
Page reviewed: August 19, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.